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Available online 15 January 2016Human neural stem cells (NSCs) hold great promise for research and therapy in neural diseases. Many studies
have shown direct induction of NSCs from human ﬁbroblasts, which require an invasive skin biopsy and a
prolonged period of expansion in cell culture prior to use. Peripheral blood (PB) is routinely used in medical di-
agnoses, and represents a noninvasive and easily accessible source of cells. Here we show direct derivation of
NSCs from adult human PBmononuclear cells (PB-MNCs) by employing episomal vectors for transgene delivery.
These induced NSCs (iNSCs) can expand more than 60 passages, can exhibit NSC morphology, gene expression,
differentiation potential, and self-renewing capability and can give rise to multiple functional neural subtypes
and glial cells in vitro. Furthermore, the iNSCs carry a speciﬁc regional identity and have electrophysiological ac-
tivity upon differentiation. Our ﬁndings provide an easily accessible approach for generating human iNSCswhich
will facilitate disease modeling, drug screening, and possibly regenerative medicine.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Induction of pluripotent stem cells from somatic cells by deﬁned
transcription factors represents a major breakthrough in cellular
reprogramming (Takahashi and Yamanaka, 2006; Takahashi et al.,
2007). Transdifferentiation from one differentiated cell type into anoth-
er by expression of lineage-related transcription factors has extended
this concept (Caiazzo et al., 2011; Yoo et al., 2011; Ieda et al., 2010;
Szabo et al., 2010; Sheng et al., 2012a). Those directly reprogrammed
somatic cells are useful tools for understanding disease processes and
discovering new therapeutics; however, they may have limited utilities
as those induced cells always have little or no proliferation potential. Di-
rect conversion of somatic cells to lineage-committed stem cells such as
neural stem cells would allow production of sufﬁcient cells for down-
stream research and clinical applications, and this approach meanwhile
reduces the risk of tumor formation.uanwuHospital, CapitalMedical
Beijing Institute of Geriatrics,
boratory of Neurodegeneration,
zhiguo@gmail.com (Z. Chen).
. This is an open access article underRecent methods of reprogramming human ﬁbroblasts to iNSCs
employed genome-integrating lentiviral or retroviral vectors (Kumar
et al., 2012; Ring et al., 2012), whichmay produce insertional mutations
and residual or reactivation of transgenes. We used oriP/EBNA-1 epi-
somal vectors to deliver reprogramming genes (OCT4, SOX2, NANOG,
LIN28, c-MYC, KLF-4 and SV40LT) (Yu et al., 2009). This approach does
not require viral packaging and the removal of episomal vectors from
iNSCs may be accomplished by cell passaging due to the inherent insta-
bility of oriP/EBNA-1 episomal state (Nanbo et al., 2007).
Up to now, the most common source from which to derive human
and mouse iNSCs has been skin ﬁbroblasts (Lu et al., 2013; Thier et al.,
2012). However, the requirement for skin biopsies and the need to ex-
pandﬁbroblasts for several passages in vitrohurdle the broad applicabil-
ity of this technology. Pei D et al. had reported using bladder-derived
cells to generate iNSCs (Wang et al., 2013); however, bladder-derived
cells can be easily contaminated by bacteria. Previous attempts to con-
vert human hematopoietic cells toward NSCs were only restricted to
the use of neonatal cord blood-derived CD34+ cells (Yu et al., 2015;
Liao et al., 2015). In fact, inducing patients' somatic cells instead of
fetal tissues into iNSCs seems to be a more practical approach. In the
present study, we succeeded to generate iNSCs from the PB-MNCs of a
33-year-old male donor, using non-integrative episomal vectors. The
iNSCs exhibited NSCmorphology, gene expression and in vitro differen-
tiation potentials.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Isolation and expansion of adult human peripheral blood mononuclear
cells
The isolation and expansion of PBMNCswas carried out as previous-
ly described (Dowey et al., 2012). Six milliliters of donor's PB was col-
lected with written informed consent, and from it around 5.6 × 106
mononuclear cells were isolated. After 2 weeks' culture, the numbers
of MNCs increased to 6.9 × 106.
2.2. Reprogramming of PB-MNCs to iNSCs by episomal vector transfection
Two million MNCs were suspended in 100 μl nucleofector solution
(Lonza, cat. no. VPA-1003, Basel, Switzerland) and then combined
with the three episomal plasmids (2 μg each) (Yu et al., 2009)
(Fig. S1). After that, the cell/DNA mixture was transferred to a sterile
cuvette (Lonza), which was placed into the cuvette holder of the
Amaxa Nucleofector II device. Following nucleotransfection using pro-
gram ‘T-016’, the solution was transferred into 2 ml MNC medium in
one well of a 12-well plate. After recovery at 37 °C, 5% CO2 for 2 days,
the cells were respectively plated on MEF-coated, Matrigel-coated or
poly-D-lysine (PDL)/laminin-coated 12-well plates at a density of
2 × 105/well. The mediumwas changed to a chemical deﬁned medium
consisting of DMEM/F12: Neurobasal (1:1), 1 × N2, 1 × B27, 1%
GlutaMAX (all from Life Technologies, Carlsbad, USA), 10 ng/ml recom-
binant human leukemia inhibitory factor (LIF, Millpore, Billerica, USA),
3 μMCHIR99021 and 2 μMSB431542 (both fromGeneOperation,Mich-
igan, USA). The medium was changed every 2 days. Eight to 10 days
later, the epithelium-like colonies appeared on all of the three culture
surfaces. Ondays 20 to 30, cell colonieswere picked up and cultured fur-
ther on PDL/laminin-coated 96-well plates for cell expansion. In the
present study, three colonies derived from MEF-coated dishes were
picked and expanded for subsequent experiments.
2.3. Neural differentiation of iNSC and regional patterning in vitro
For patterning and terminal differentiation of iNSCs, a modiﬁed pro-
tocol previously described by Zhang was used (Lu et al., 2013). Brieﬂy,
LIF, CHIR, and SBwere removed from themedium, and small molecules,
1 μMretinoic acid (RA, Sigma-Aldrich, St. Louis,Missouri, USA) and 1 μM
SAG1 (Enzo, New York, USA) were added to the medium for 2 weeks.
For terminal differentiation, iNSCs were seeded at a density of 1 × 104
cells per 12 mm glass coverslip that had been coated with PDL/laminin
in a neural differentiation medium (DMEM/F12 with 1 × N2, 1 × B27,
1 × NEAA supplemented with 100 ng/ml cAMP (Sigma-Aldrich),
10 ng/ml GDNF, 10 ng/ml BDNF, 10 ng/ml IGF-1 and 10 ng/ml
neurotrophin 3 (NT3) (all from PeproTech, Rocky Hill, USA). To derive
oligodendrocytes, iNSCs were seeded at a density of 20,000 cells per
12 mm glass coverslip coated with PDL /laminin and cultured in neural
differentiation medium supplemented with RA (1 μM, Sigma-Aldrich),
PDGF-AB (20 ng/ml, PeproTech), bFGF (10 ng/ml, PeproTech), SAG1
(1 μM, Enzo) for 2 weeks as described by HU (Hu et al., 2009). After-
wards, RA and bFGF were replaced with T3 (60 ng/ml), cAMP (1 mM)
(both from Sigma-Aldrich), insulin-like growth factor 1 (IGF1), NT3
(all at 10 ng/ml from PeproTech) for another 6 weeks.
2.4. Immunocytochemistry
Cells were washed 3 times with PBS and ﬁxed by 4% paraformalde-
hyde (PFA, Sigma-Aldrich) for 10 min. For immunoﬂuorescence
staining, cells were blocked by 3% donkey serum (Jackson
ImmunoResearch, West Grove, PA) in 0.3% Triton-TBS for 1 h, and incu-
bated with primary antibodies overnight at 4 °C followed by secondary
antibody staining for 2 h at room temperature. All primary antibodies,
sources, and dilutions were listed in Table S1. After nuclear stainingwith DAPI (Sigma-Aldrich), cell populations were counted using
Image J software. At least nine ﬁelds of each coverslip were chosen ran-
domly, and three coverslips in each group were counted. Data were
expressed asmean±SEM. Error bars represent SEM. Pictureswere cap-
tured by using Leica TCS SP5 confocal microscope (Leica, Mannheim,
Germany).
2.5. Ethics statement and isolation of fetal NSCs
Human tissues were donated for research after written informed
consent of the women seeking abortion. Tissue procurement was per-
formed in accordance with the Declaration of Helsinki and the study
protocol was approved by Institutional Review Committee of Xuanwu
Hospital, Capital Medical University. The isolation of fetal brain NSCs
was applied as described before (Wang et al., 2010). Brieﬂy, cerebral
cortical tissue was gently dissected into small pieces (about 1 mm3),
and the minced tissue was triturated gently with Pasteur pipet in
15 ml centrifuge tube (Corning, New York, USA) and was pelleted by
gravity for 5 min. Then the supernatant was ﬁltrated with 50-μm cell
strainer and the cells were plated onto 10 cm well plates (Corning) in
NSC medium consisting of DMEM-F12 (Life Technologies), 20 ng/ml
bFGF (PeproTech), 20 ng/ml EGF (PeproTech), 2% B27 (Life Technolo-
gies) and 1% penicillin–streptomycin (Life Technologies) and incubated
at 37 °C in 5% CO2 atmosphere.
2.6. PCR, RNA isolation and RT-PCR
Genomic DNAs were extracted using the Wizard Genomic DNA Pu-
riﬁcation Kit (Promega, Madison, USA) for PCR analysis using primers
shown in (Table S2). RNA isolation was performed using the RNeasy
plus Mini Kit (Qiagen, Hilden, Germany). Brieﬂy, cells were pelleted,
washed with PBS and resuspended in lysis buffer. RNA was eluted in
30 μl distilled water. The reverse transcription was carried out with
the GoScript™ Reverse Transcription System (Promega, Madison,
USA). RT-PCR analyses for detection of transgenes and regionalization
markers were carried out using the primer pairs and annealing temper-
atures listed in Table S2. The PCR-program: 94 °C 2 min, 94 °C 30 s, X °C
30 s, 72 °C 1 min, 72 °C 7 min. Steps 2–4 were repeated 35 times.
2.7. Karyotype analysis
Karyotype analysis was carried out as described (Duinsbergen et al.,
2008). Brieﬂy, cycling cells were incubated with 100 ng/ml colcemid
(Life Technologies) for 90 min, after which they were ﬁxed with an ice
cold methanol:glacial acetic (3:1) solution for 3 times. Chromosomes
were stained with Hoechst (Life Technologies) and counted using a
630× magniﬁcation.
2.8. Electrophysiology
Whole cell patch clamp recording was performed on passage 20
iNSC–derived neurons after 7 weeks of differentiation in medium con-
taining DMEM/F12 with 1 × N2, 1 × B27, 1 × NEAA supplemented
with 100 ng/ml cAMP (Sigma-Aldrich), 10 ng/ml GDNF, 10 ng/ml
BDNF, 10 ng/ml IGF-1 and 10 ng/ml neurotrophin 3 (NT3) (all from
PeproTech). Cells were bathed in artiﬁcial cerebrospinal ﬂuid (in mM:
126 NaCl, 2.5 KCl, 2 CaCl2, 1.25 NaH2PO4, 2 MgSO4, 25 glucose, and
26 NaHCO3). Internal solution consisted of (in mM: 143 KCl, 8 NaCl 10
HEPES, 1 MgCl2, 2 NaATP, and 0.4 NaGTP). Cells were visualized on an
Olympus BX51WI system. Electrode resistance was 3–5 MΩ. Action po-
tentials were induced in current clamp mode using a HEKA EPC-10
patch-clamp ampliﬁer (HEKA Electronic Inc., Germany). Series resis-
tance was constantly monitored and results were not included if signif-
icant variation (N20%) occurred during an experiment. Data acquisition
and analysis were performed using PatchMaster and Igor software.
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3.1. Generation of iNSCs from adult human peripheral blood mononuclear
cells by a non-integrative method
Blood MNCs without lymphocytes and CD34+ hematopoietic stem
cells (HSCs) possess epigenetic signatures that are closer than those of
age-matched ﬁbroblasts to embryonic stem cells and iPSCs after a
brief culture (Dowey et al., 2012; Ye et al., 2009; Chou et al., 2011). So
we tried to induce iNSCs from adult human blood MNCs. PB-MNCs
(Fig. 1B) were isolated from the peripheral blood of a 33-year-old
male donor. Human PB-MNCs were negative for pluripotent markers,
SSEA4 and TRA1-60 (Fig. S2A and B), and early neural markers, Nestin
and Sox1, (Fig. S2C and D), thereby excluding the presence of contami-
nating cells with pluripotent or NSC features within the starting cells.
The MNCs were transfected with oriP/EBNA1-based episomal vectors
containing OCT4, SOX2, NANOG, LIN28, c-Myc and KLF4 (Yu et al.,
2009). After that, cells were cultured inMNCsmedium for 2 days for re-
covery and followed by culture in deﬁned basal medium containing LIF,
SB and CHIR on irradiated MEF, Matrigel, or PDL/laminin, respectively.
As early as day 10 post-electroporation, compact colonies appeared in
some wells (Fig. 1C) (the number of colonies listed in Table S3). The
neuroepithelia-like colonies grew rapidly in the following weeks andFig. 1.Generation of iNSCs fromadult human bloodmononuclear cells. (A) Schematic drawing o
cultured for 14 days before transfection. (C) A neural epithelium-like colony appeared on ME
(E) Morphology of iNSCs when cultured in a PDL/laminin-coated culture dish. (F) iNSCs form
expanded iNSCs (P20). Primers were designed to detect exogenous reprogramming fac
reprogramming factors for 2 days served as a positive control. GAPDHwas used as a loading coby day 30, they were large enough to be selected manually. In the cur-
rent study, three colonies cultured on irradiated MEF were picked for
further studies. (Fig. 1D). These cells grew well when cultured either
as monolayer (Fig. 1E) or as spheres (Fig. 1F). PCR analysis failed to de-
tect genomic integration of episomal vectors (Fig. 1G) and the
transgenes were gradually lost over passages (Fig. S3). We took cells
at passage 2 for karyotype analysis, which showed a normal karyotype
(Fig. 1H).3.2. iNSCs are similar to brain-derived NSCs
To examine the identity of the induced cells, we compared them
with 12-week fetal brain-derived neural stem cells. Both expressed
Sox1, Sox2, and Nestin (Fig. 2A and B), markers of NSCs. Meanwhile,
the induced cells are negative for pluripotency markers SSEA4 and
TRA1-60 (Fig. 2C and D). RT-PCR analysis conﬁrmed that the induced
cells expressed FABP7, SOX2, HES5, and SOX1 (Fig. 2F), all of which
were characteristic markers of NSCs (Conti et al., 2005). Next, we
assessed the capability of iNSCs to self-renew under proliferation
conditions. The induced cells were positive for Ki67 (70.10% ±
6.50%, Fig. 2E) and the cell numbers steadily increased overtime
(Fig. 2G).f iNSCs generation procedure. (B) Adult humanbloodmononuclear cellswere isolated and
Fs at day 10 after transfection. (D) The neural epithelium-like colony expanded quickly.
ed neurospheres when kept in suspension culture. (G) PCR detection of transgenes in
tors. Untransfected MNCs served as a negative control. PB-MNCs transfected with
ntrol. PC, positive controls. (H) Karyotype of human iNSCs at passage 2. Scale bars: 100 μm.
Fig. 2.Characterizations of induced neural stem cells. (A) Human fetal brain-derivedNSCs stainedpositive for Nestin (left, green), Sox1 (middle, red), and Sox2 (right, red). Blue represents
DAPI staining. (B)Human adult peripheral blood-derived iNSCswerepositive forNestin (left, green), Sox1 (middle, red), and Sox2 (right, red). (CD)Human iNSCswerenegative for SSEA4
and TRA1-60. (E) Immunostaining for Ki67 (red). (F) RT-PCR analysis showed that human iNSCs expressed neural stem cell markers: SOX1, SOX2, FABP7, and HES5. Uninfected MNCs
served as a negative control and fetal brain NSCs as a positive control. (G) Growth curve of three human iNSC cell lines. Cells at passage 6 were used as initial cells. Scale bars: 50 μm
(A–E).
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cyte progenitor cells
To access the differentiation potential, iNSCs (at passage 20)were cul-
tured on PDL/laminin-coated coverslips in a neural differentiation medi-
um (Fig. 3A). After spontaneous differentiation for 7 weeks, a majority of
the cells became MAP2+ neurons (64.75% ± 3.59% of total cells, Fig. 3B
and H), and many of the MAP2+ neurons co-expressed NeuN. Around
6.79% ± 1.08% of total cells were GFAP+ astrocytes (Fig. 3C and I). A
large population of the matured neurons expressed PSD95 and vGlut1
(Fig. 3D), indicating that synaptic proteins are present in the neurons
and that the formation of synapses is possible. To generate dopaminergic
neurons, we ﬁrst treated iNSCs with SAG1 and FGF8 for 2 weeks, and
then changedmedium to DMEM/F12 with BDNF, GDNF, NT3 for another
3weeks (Colleoni et al., 2010). In this way, around 8.15%±1.89% of total
cells became TH+ dopaminergic neurons (Fig. 3E and I). The human
iNSCs did not give rise to O1+oligodendrocytes during spontaneous dif-
ferentiation (data not shown) (Hu et al., 2009). After treatment withSAG1, RA, PDGF-AB, bFGF for 2 weeks, some PDGFRα+oligodendrocyte
precursor cells (pre-OPC) were observed in the culture (Fig. 3F and J).
When further cultured in the glial differentiation medium for 6 weeks,
O1+oligodendrocyteswere detected (Fig. 3G and J). Next, we examined
the functional properties of iNSCs-derived neurons by patch clamp re-
cording. When differentiated for 7 weeks, action potentials can be trig-
gered in some neurons by injection of current steps from−60 to +40
PA (Fig. 3K). Both inward Na+ and outward K+ currents were observed
by voltage clamp recording (Fig. 3L). In addition, we tested the differen-
tiation of iNSCs at early passages. iNSCs at passage 3were capable of neu-
ronal differentiation and the exogenous transgenes were gradually lost
along the differentiation course (Fig. S4).
3.4. iNSCs possess region-speciﬁc characteristics and can be patterned to
hindbrain cell fates
Neural progenitors derived from pluripotent stem cells may carry a
regional identity (Lu et al., 2013; Zhang et al., 2011). We explored if
Fig. 3. Differentiation and functional properties of iNSCs in vitro. (A) Schematic drawing of the differentiation process. (B–G) Immunostaining of spontaneously differentiated iNSCs for
7 weeks with the indicated markers. vGlut1, PSD95, pre and postsynaptic makers; TH, tyrosine hydroxylase. (H) Percentage of neurons (MAP2-positive cells) in three spontaneously
differentiated iNSCs cell lines at passage 20. The number of total cells was determined by DAPI staining. (I) Percentage of astrocytes (GFAP-positive cells) and dopamine neurons (TH-
positive cells) in two differentiated cell lines. (J) Percentage of Pre-OPC (PDGFR-α-positive cells) and OPC(O1-positive cells)in two differentiated cell lines. (K) iNSCs-derived neurons
were assessed by whole-cell patch clamp recording. Action potentials were induced by injected current steps from−60 to +40 PA. (L) Inward Na+ and outward K+ currents were
triggered upon applying voltage steps from−50 mV to +50 mV. Scale bars: 50 μm (B, C, E–G), 15 μm(D).
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Interestingly, iNSCs expressed Nurr1 (a midbrain marker) and Otx2 (a
forebrain/midbrain marker) by immunostaining (Fig. 4A and B) and
RT-PCR analysis (Fig. 4C). In addition, the iNSCs also expressed some an-
terior hindbrain markers, including GBX2, KROX20, HOXA2, and
HOXA3, but not expressing OLIG2, a marker of ventral hindbrain
(Fig. 4C). We then tried to explore if such a regional fate may be altered
by treating the stable iNSCs lineswithmorphogens of posterior pattern-
ing reagent. After treatment with RA (1 μM) and SAG1 (1 μM) for
2 weeks, the human iNSCs expressed the ventral hindbrain markers
Olig2 and Hoxb4 (Fig. 4D). Following further differentiation without
RA and SAG1 for another 3 weeks, a large proportion of the Tuj1+ neu-
rons expressed ISLET1 and HB9, markers of spinal cord motor neurons.
In contrast, iNSCs cultured in the absence of SAG1 and RA did not ex-
press ISLET1 or HB9 (Fig. 4E). These results indicate that the iNSCs
may possess certain region-speciﬁcity but are primitive enough to be
patterned to ventral hindbrain and more caudal neural types.
4. Discussion
In this study, we have successfully derived iNSCs from adult human
PB-MNCs using non-integrative episomal vectors. These iNSCs can ex-
pand to a large number and easily differentiate to neurons, astrocytes,
and oligodendrocytes. Many labs have reported generation of iNSCs
from skin ﬁbroblasts (Sheng et al., 2012a; Kumar et al., 2012; Nanbo
et al., 2007; Lu et al., 2013). Fibroblasts are the cellular source for
many reprogramming experiments performed in recent years, but
may not be the best choice for directed reprogramming. Acquiring a
sample of this sort involves a skin biopsy,which requires patients to un-
dergo procedures such as local anesthesia, an incision, and suturing. All
of these interventions are facedwith potential complications, especiallylocal or general infection. Additionally, using skin as a source for iNSC
line derivation poses the risk thatﬁbroblasts harbor chromosomal aber-
rations caused byUV (Abyzov et al., 2012). Pei et al. had reported the di-
rect generation of iNSCs from human bladder-derived cells (Thier et al.,
2012), but the patients' urine in ward may easily be contaminated by
bacteria. Peripheral blood is routinely used in medical diagnoses and
represents a noninvasive and easily accessible source of cells for
reprogramming from both healthy donors and disease-speciﬁc patients.
Some labs have reported generation of human induced pluripotent
stem cells from peripheral blood cells (Staerk et al., 2010; Kunisato
et al., 2011; Seki et al., 2012). Recently, Julio reported generation of ex-
pandable iNSCs from CD133-positive cord blood cells and PB-MNCs
using Sendai virus encoding SOX2 and c-MYC (Castano et al., 2014).
However, using this method, MNC-derived iNSCs only showed limited
expansion (only a few cells are positive for Ki67), poor differentiation
capacity and no electrophysiological functions from differentiated neu-
rons. These limitations will greatly restrict its clinical applicability; in
our study, iNSCs derived from adult human PB can easily expand for
more than 60 passages, and the resulting mature neurons possess elec-
trophysiological functions. The method described in this study may be
more acceptable and readily accessible to patients with neurological
disorders to generate iNSCs for disease modeling, and/or, possibly, re-
placement therapy.
At present, the strategies for direct generation of iNSCs from somatic
cells can be broadly classiﬁed into two groups according to whether the
procedure passes through intermediate or pluripotent state. Lujen et al.
generated iNSCs from ﬁbroblasts by introducing Brn2, Sox2, and FoxG1;
but the iNPCs require constant expression of transgenes and generate
less mature neurons (Lujan et al., 2012). Our lab and collaborators
used pax6, Ngn2, Hes1, Id1, Ascl1, Brn2, c-myc and Klf4 to produce
iNSCs from mouse Sertoli cells (Sheng et al., 2012b; Wu et al., 2015),
Fig. 4. Region speciﬁcity and plasticity of iNSCs. (A–B) iNSCs expressed the midbrain marker Nurr1 and anterior/midbrain neural marker Otx2. (C) Gene expression of iNSCs. (D) iNSCs
were negative for hindbrain markers Olig2 and Hoxb4. However, after treatment with RA and SAG1 for 14 days, most iNSCs were positive for Olig2, and Hoxb4 — a marker for spinal
cord motor neuron precursors. (E) Differentiation of iNSCs gave rise to neurons negative for HB9 and ISLET1. After treatment with RA and SAG1 for 2 weeks and then cultured in
neuronal differentiation medium for another 3 weeks, a majority of neurons were positive for HB9 and ISLET1. Scale bars: 50 μm.
241X. Tang et al. / Stem Cell Research 16 (2016) 236–242but the same reprogramming strategy did not work well with human
cells (data not shown). The above twomethods did not involve passing
through an intermediate states. Other studies employed part or all of
the four Yamanaka reprogramming factors (Lu et al., 2013; Thier et al.,
2012; Wang et al., 2013; Han et al., 2012; Kim et al., 2011; Lee et al.,
2015) to derive iNSCs which can stably self-renew and differentiate to
functional neuronal subtypes and astroglia. Our induction strategy in-
cludes two major steps and employs a non-integrative approach: the
ﬁrst two days after infection is for inducing an intermediate state,
followed by several days for lineage-speciﬁc induction (Fig. 1A). The
conversion and maintenance of iNSC phenotype are also dependent
on the chemical deﬁned medium. LIF is required for long-term self-
renewal of primitive NSCs (Hitoshi et al., 2004), and CHIR99021, the
GSK 3β inhibitor can direct human embryonic stem cells to a pre-
neuroepithelial state (Denham et al., 2012; Wang et al., 2015).
SB431542 as a TGFβ receptor inhibitor can promote neuronal speciﬁca-
tion in early neural development (Smith et al., 2008). The combination
of LIF, GSK3β inhibitor, and TGFβ receptor inhibitor is critical for the
generation of neural stem cells from intermediate states.5. Conclusion
In this study, we have demonstrated the direct generation of stably
expandable iNSCs from adult human peripheral blood mononuclear
cells by a non-integrative method, which may provide a convenient
platform to obtain patient-speciﬁc neural cells for disease modeling,
drug screening, and medical applications.
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